Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Exploratory Study of EVA-001 for Osteoarthritis of the Knee
jRCT2033210138Phase 2Suspended
- Sponsor
- Evastem
- Start
- Jun 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of EVA-001 in knee osteoarthritis (OA) (2 arms), sponsored by Evastem. Started Jun 2020; status: suspended.
02
Drugs
EVA-001
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2033210138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2033210138.